SCHEMBL17664339

SCHEMBL17664339

Cc1cccc(CNC(=O)N/C=C/c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 1/20 0.41
▸ AR P10275 4/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ CES2 O00748 1/20 0.40
▸ ABCB11 O95342 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.40
▸ CHRM1 P11229 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ TBXA2R P21731 1/20 0.40
▸ AADAC P22760 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ ADRA1A P35348 1/20 0.40
▸ HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17664223 0.90 ATG4B (0.49) PTPN1ALDH1A1CYP3A4LMNACYP1A2
SCHEMBL17664338 0.79 DDT (0.53) ALDH1A1CYP3A4LMNACYP1A2CYP2C19
SCHEMBL17664233 0.72 MLYCD (0.53) ALDH1A1CYP3A4LMNACYP1A2CYP2C19
SCHEMBL17664230 0.71 LMNA (0.52) ALDH1A1LMNAMAPTATG4BFBP1
SCHEMBL23447432 0.69 MLYCD (0.58) CYP3A4LMNACYP1A2CYP2C19SMN1; SMN2
SCHEMBL6119720 0.67 CYP3A4 (0.60) ARALDH1A1CYP3A4LMNACES2
SCHEMBL17664228 0.67 CA12 (0.51) PTPN1ARALDH1A1CYP3A4LMNA
SCHEMBL16957012 0.67 AR (0.49) ARALDH1A1CYP3A4LMNACES2
SCHEMBL17664294 0.66 AR (0.51) ARALDH1A1CYP3A4LMNACES2
SCHEMBL11305513 0.66 AR (0.51) ARALDH1A1CYP3A4LMNACES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016049774-A1 UREA AND BIS-UREA BASED COMPOUNDS AND ANALOGUES THEREOF USEFUL IN THE TREATMENT OF ANDROGEN RECEPTOR MEDIATED DISEASES OR DISORDERS THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2016-04-07 — — WO disclosed
Send feedback